Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Research grant seeks to understand how beliefs about cancer treatment outcomes affect symptom management, aiming to leverage expectancy effects for improved cancer care for diverse populations.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision) | June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.
Summary: Supports mechanistic clinical research on how expectancy effects influence cancer symptom management, with emphasis on diverse and underserved populations.
Key Information: Clinical trial required; applications must use an experimental medicine approach and cannot use deceptive placebo conditions.
Description
This opportunity from the National Institutes of Health (NIH), led by the National Cancer Institute (NCI), funds mechanistic clinical research to understand how expectancy effects—beliefs about future outcomes—impact cancer symptom management. The program seeks to identify factors that generate expectancies, measure their effects, and determine how these can be leveraged to improve cancer outcomes, particularly among populations historically underrepresented or excluded from biomedical and behavioral research.
Expectancy effects may be shaped by social, psychological, environmental, and systemic factors, and can be held by patients, clinicians, caregivers, or social networks. The program is especially interested in research that addresses disparities in cancer symptom management and includes medically underserved groups.
